213 related articles for article (PubMed ID: 35350405)
1. Undetected αKlotho in serum is associated with the most aggressive phenotype of breast cancer.
Borges BC; Do Amaral PA; Soldi LR; Costa Silva VL; Carvalho De Souza F; Cordeiro Da Luz FA; Agenor De Araújo R; Barbosa Silva MJ
Mol Clin Oncol; 2022 Apr; 16(4):93. PubMed ID: 35350405
[TBL] [Abstract][Full Text] [Related]
2. The anti-aging protein alpha-Klotho in systemic sclerosis patients: does a relationship to telangiectasia exist?
Niazy MH; Gaber W; Sayed S; Shaker OG; Gheita TA
Z Rheumatol; 2020 May; 79(4):404-409. PubMed ID: 31602506
[TBL] [Abstract][Full Text] [Related]
3. Klotho in Cancer: Potential Diagnostic and Prognostic Applications.
Mota J; Lima AMM; Gomes JIS; Souza de Andrade M; Brito HO; Silva MMAL; Faustino-Rocha AI; Oliveira PA; Lopes FF; Gil da Costa RM
Diagnostics (Basel); 2023 Oct; 13(21):. PubMed ID: 37958253
[TBL] [Abstract][Full Text] [Related]
4. Expression and prognostic value of estrogen receptor β in patients with triple-negative and triple-positive breast cancer.
Guo L; Zhu Q; Aisimutuola M; Yilamu D; Liu S; Jakulin A
Exp Ther Med; 2015 Jun; 9(6):2147-2150. PubMed ID: 26136950
[TBL] [Abstract][Full Text] [Related]
5. Vitamin D deficiency is associated with poor breast cancer prognostic features in postmenopausal women.
de Sousa Almeida-Filho B; De Luca Vespoli H; Pessoa EC; Machado M; Nahas-Neto J; Nahas EAP
J Steroid Biochem Mol Biol; 2017 Nov; 174():284-289. PubMed ID: 29031688
[TBL] [Abstract][Full Text] [Related]
6. The demonstration of αKlotho deficiency in human chronic kidney disease with a novel synthetic antibody.
Barker SL; Pastor J; Carranza D; Quiñones H; Griffith C; Goetz R; Mohammadi M; Ye J; Zhang J; Hu MC; Kuro-o M; Moe OW; Sidhu SS
Nephrol Dial Transplant; 2015 Feb; 30(2):223-33. PubMed ID: 25324355
[TBL] [Abstract][Full Text] [Related]
7. Knockdown of PTEN decreases expression of estrogen receptor β and tamoxifen sensitivity of human breast cancer cells.
Treeck O; Schüler-Toprak S; Skrzypczak M; Weber F; Ortmann O
Steroids; 2020 Jan; 153():108521. PubMed ID: 31604073
[TBL] [Abstract][Full Text] [Related]
8. Serum αKlotho as a Predictor of Graft Dysfunction After Kidney Transplantation.
Tsujita M; Kosugi T; Masuda T; Okada M; Futamura K; Hiramitsu T; Goto N; Shunji N; Watarai Y; Maruyama S
Transplant Proc; 2018 Dec; 50(10):3440-3444. PubMed ID: 30577218
[TBL] [Abstract][Full Text] [Related]
9. αKlotho and Chronic Kidney Disease.
Neyra JA; Hu MC
Vitam Horm; 2016; 101():257-310. PubMed ID: 27125746
[TBL] [Abstract][Full Text] [Related]
10. Forkhead box transcription factor FOXO3a suppresses estrogen-dependent breast cancer cell proliferation and tumorigenesis.
Zou Y; Tsai WB; Cheng CJ; Hsu C; Chung YM; Li PC; Lin SH; Hu MC
Breast Cancer Res; 2008; 10(1):R21. PubMed ID: 18312651
[TBL] [Abstract][Full Text] [Related]
11. Alpha-Klotho, a critical protein for lung health, is not expressed in normal lung.
Zhang J; Cao K; Pastor JV; Li L; Moe OW; Hsia CCW
FASEB Bioadv; 2019 Nov; 1(11):675-687. PubMed ID: 32123814
[TBL] [Abstract][Full Text] [Related]
12. Estrogen receptor β selective agonists reduce invasiveness of triple-negative breast cancer cells.
Hinsche O; Girgert R; Emons G; Gründker C
Int J Oncol; 2015 Feb; 46(2):878-84. PubMed ID: 25420519
[TBL] [Abstract][Full Text] [Related]
13. Role of Fibroblast Growth Factor 23 (FGF23) and αKlotho in Cancer.
Ewendt F; Feger M; Föller M
Front Cell Dev Biol; 2020; 8():601006. PubMed ID: 33520985
[TBL] [Abstract][Full Text] [Related]
14. Estrogen receptor beta growth-inhibitory effects are repressed through activation of MAPK and PI3K signalling in mammary epithelial and breast cancer cells.
Cotrim CZ; Fabris V; Doria ML; Lindberg K; Gustafsson JÅ; Amado F; Lanari C; Helguero LA
Oncogene; 2013 May; 32(19):2390-402. PubMed ID: 22751110
[TBL] [Abstract][Full Text] [Related]
15. Fulvestrant inhibits growth of triple negative breast cancer and synergizes with tamoxifen in ERα positive breast cancer by up-regulation of ERβ.
Mishra AK; Abrahamsson A; Dabrosin C
Oncotarget; 2016 Aug; 7(35):56876-56888. PubMed ID: 27486755
[TBL] [Abstract][Full Text] [Related]
16. c-Met and ERβ expression differences in basal-like and non-basal-like triple-negative breast cancer.
Ren X; Yuan L; Shen S; Wu H; Lu J; Liang Z
Tumour Biol; 2016 Aug; 37(8):11385-95. PubMed ID: 26968553
[TBL] [Abstract][Full Text] [Related]
17. Estrogen receptor-beta is a potential target for triple negative breast cancer treatment.
Austin D; Hamilton N; Elshimali Y; Pietras R; Wu Y; Vadgama J
Oncotarget; 2018 Sep; 9(74):33912-33930. PubMed ID: 30338035
[TBL] [Abstract][Full Text] [Related]
18. CpG island methylation profile of estrogen receptor alpha in Iranian females with triple negative or non-triple negative breast cancer: new marker of poor prognosis.
Ramezani F; Salami S; Omrani MD; Maleki D
Asian Pac J Cancer Prev; 2012; 13(2):451-7. PubMed ID: 22524805
[TBL] [Abstract][Full Text] [Related]
19. Differences in clinical importance of Bcl-2 in breast cancer according to hormone receptors status or adjuvant endocrine therapy.
Honma N; Horii R; Ito Y; Saji S; Younes M; Iwase T; Akiyama F
BMC Cancer; 2015 Oct; 15():698. PubMed ID: 26472348
[TBL] [Abstract][Full Text] [Related]
20. Histochemical Examination on Periodontal Tissues of Klotho-Deficient Mice Fed With Phosphate-Insufficient Diet.
Hikone K; Hasegawa T; Tsuchiya E; Hongo H; Sasaki M; Yamamoto T; Kudo A; Oda K; Haraguchi M; de Freitas PH; Li M; Iida J; Amizuka N
J Histochem Cytochem; 2017 Apr; 65(4):207-221. PubMed ID: 28122194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
